Q3 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: iBio(IBIO) the Revenue is 0 (--%), Miss estimate;the EBIT is -8.365 M (-71.45%), Miss estimate;the EPS is -0.06 (+87.76%), Meet estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B--
0.00B--
-0.00B--%
EBITMiss expectations
-0.01B71.45%
-0.01B50.11%
-0.00B21.34%
EPS
-0.0687.76%
-0.0687.76%
0.00000.00%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf